tradingkey.logo
tradingkey.logo

Crossbow Therapeutics Raises $77 Million In Series B Financing To Advance Development Of Tcr-Mimetic Antibody Therapies To Treat Cancer

ReutersMar 18, 2026 12:32 PM

-

  • CROSSBOW THERAPEUTICS RAISES $77 MILLION IN SERIES B FINANCING TO ADVANCE DEVELOPMENT OF TCR-MIMETIC ANTIBODY THERAPIES TO TREAT CANCER

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI